An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma

BACKGROUND: The prognosis of children with metastatic stage 4 neuroblastoma (NB) has remained poor in the past decade. PATIENTS AND METHODS: Using microarray analyses of 342 primary tumors, we here developed and validated an easy to use gene expression-based risk score including 18 genes, which can...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Transl Med
Päätekijät: Formicola, Daniela, Petrosino, Giuseppe, Lasorsa, Vito Alessandro, Pignataro, Piero, Cimmino, Flora, Vetrella, Simona, Longo, Luca, Tonini, Gian Paolo, Oberthuer, André, Iolascon, Achille, Fischer, Matthias, Capasso, Mario
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4870777/
https://ncbi.nlm.nih.gov/pubmed/27188717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-0896-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia